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Abstract
Background: Signals between stem cells and stroma are important in establishing the stem cell niche. However, very little is
known about the regulation of any mammalian stem cell niche as pure isolates of stem cells and their adjacent
mesenchyme are not readily available. The prostate offers a unique model to study signals between stem cells and their
adjacent stroma as in the embryonic prostate stem cell niche, the urogenital sinus mesenchyme is easily separated from the
epithelial stem cells. Here we investigate the distinctive molecular signals of these two stem cell compartments in a
mammalian system.
Methodology/Principal Findings: We isolated fetal murine urogenital sinus epithelium and urogenital sinus mesenchyme
and determined their differentially expressed genes. To distinguish transcripts that are shared by other developing
epithelial/mesenchymal compartments from those that pertain to the prostate stem cell niche, we also determined the
global gene expression of epidermis and dermis of the same embryos. Our analysis indicates that several of the key
transcriptional components that are predicted to be active in the embryonic prostate stem cell niche regulate processes
such as self-renewal (e.g., E2f and Ap2), lipid metabolism (e.g., Srebp1) and cell migration (e.g., Areb6 and Rreb1). Several of
the enriched promoter binding motifs are shared between the prostate epithelial/mesenchymal compartments and their
epidermis/dermis counterparts, indicating their likely relevance in epithelial/mesenchymal signaling in primitive cellular
compartments. Based on differential gene expression we also defined ligand-receptor interactions that may be part of the
molecular interplay of the embryonic prostate stem cell niche.
Conclusions/Significance: We provide a comprehensive description of the transcriptional program of the major regulators
that are likely to control the cellular interactions in the embryonic prostatic stem cell niche, many of which may be common
to mammalian niches in general. This study provides a comprehensive source for further studies of mesenchymal/epithelial
interactions in the prostate stem cell niche. The elucidation of pathways in the normal primitive niche may provide greater
insight into mechanisms subverted during abnormal proliferative and oncogenic processes. Understanding these events
may result in the development of specific targeted therapies for prostatic diseases such as benign prostatic hypertrophy
and carcinomas.
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cell niche may therefore result in the development of specific
targeted therapies for these two common prostatic diseases.
In this study we generated a compendium of transcripts that are
differentially expressed in embryonic UGE versus UGM. We
further utilized computational gene expression analysis to decipher
the potential transcriptional factors (TFs) and the main biological
functionalities that are predicted to characterize the embryonic
prostatic stem cell niche. The transcriptional components that are
likely to be active in the embryonic prostate stem cell niche may
regulate processes such as self-renewal (e.g., E2f and Ap2), lipid
metabolism (e.g., Srebp1) and cell migration (e.g., Areb6 and
Rreb1). In addition, based on their differential expression levels,
we offer several ligand-receptor interactions that may be relevant
in controlling signals in the stem cell niche including the Wnt/bcatenin, ephrin, Notch, Sonic hedgehog (Shh), FGF, TGF-b and
bone morphogenic protein signaling pathways.

Introduction
Stem cells reside within restricted microenvironments known as
niches. Quiescence, self-renewal and differentiation of stem cells
are regulated by intrinsic and extrinsic mechanisms. Intrinsic
mechanisms include those that alter the epigenetic state of these
cells such as those regulated by chromatin modifiers like the
polycomb group proteins. Extrinsic mechanisms comprise those
regulated by the niche and include direct interactions between
stem cells and their supporting mesenchyme mediated by integrins
and cadherins as well as locally secreted and membrane-bound
growth factors. Elucidating the important signals in stem cell
niches may delineate the mechanisms involved in regulating stem
cell self-renewal and the maintenance of their multipotentiality.
The best characterized mammalian stem cell niches are the
epidermal niche in the bulge region of the hair follicle [1], the
intestinal epithelial niche [2], the hematopoietic stem cell niche in
the bone marrow [3] and the neuronal stem cell niche [4].
Although these niches encompass a wide variety of cells and tissues
they share a number of common properties. First, each niche
contains a supportive stromal element that may differ depending
on the niche. For example endothelial cells nurture the neuronal
niche while N-cadehrin-positive osteoblastic lining cells support
the hematopoietic stem cell niche. Second, the niche provides
physical contact and anchoring that is necessary for stem cell selfrenewal. Adhesion molecules such integrins and E- and Ncadherin anchor stem cells to the extracellular matrix. Third,
extrinsic factors that control the number and fate of the stem cell
population are generated within the niche. These include various
signaling molecules such as the Wnts, bone morphogenic proteins
(BMPs), fibroblast growth factors (FGFs), Notch and Shh that
control, positively and negatively, the self-renewal and commitment of stem cells. An important function of the niche is to
regulate precisely the balance between self-renewal and differentiation in order to maintain optimal organ function at all times.
The aberrant proliferation of stem cells within the niche may result
in tumorigenesis. Therefore, one of the most important functions
of the niche is its ability to regulate the balance between stem cell
self renewal and quiescence [5].
In the adult animal the prostatic stem cell niche resides in the
proximal region of murine prostatic ducts [6,7,8]. Interestingly,
this is also the site of origin of prostate tumors [9], indicating that
these may arise in stem cells. Although prostatic epithelial stem
cells can be isolated from this region based on their high
expression of Sca-1 [6,10], their corresponding adjacent mesenchyme cannot be isolated due to lack of identifiable markers. In
order to gain insights into the mechanisms that regulate the stem
cell niche in the prostate we isolated epithelial cells (urogenital
sinus epithelium, UGE) and their adjacent mesenchyme (urogenital sinus mesenchyme, UGM) from the embryological niche
(urogenital sinus, UGS) from which the prostate develops [11]. To
our knowledge this is the only mammalian stem cell niche from
which pure samples of both the epithelial stem cells and their
surrounding mesenchyme can readily be obtained.
The prostatic mesenchyme has a significant role in regulating
the growth and behavior of the adjacent prostatic epithelium
[7,11]. Indeed, perturbations in growth factor production by the
mesenchyme can induce tumors in the adjacent normal epithelium
[12,13]. Many of the epithelial/mesenchymal interactions uncovered in the embryonic prostatic niche are likely to be maintained
in the adult niche. Perturbations in these signals may result in
benign prostatic hyperplasia and prostate carcinomas as both of
these diseases are thought to arise from aberrant stem cell
proliferation. Understanding the interactions in the prostate stem
PLoS ONE | www.plosone.org

Materials and Methods
Cell preparation
Isolation of cell populations. All animal care and procedures
were performed in compliance with New York University
institutional review board requirements. UGE and UGM were
isolated from the urogenital sinus of 16-day-old C57BL/6 murine
embryos after digestion with trypsin [14] and added to TRIzol.
Epidermis and dermis were prepared from skin removed from the
back of E16 mouse embryos. Skin was incubated overnight at 4uC
in 2 ml of Dispase solution (Gibco, Grand Island, NY, Cat. No,
17105-041, 0.4 mg/ml) in DMEM containing 10% FCS [15,16].
The dermis and epidermis were separated manually using a
dissecting microscope and added to TRIzol.

Real-Time PCR
One mg of total RNA was reverse-transcribed at 52u C for
1 hour using the Thermoscript RT-PCR system (Invitrogen,
Carlsbad, CA). 20 ng of resultant cDNA was used in a Q-PCR
reaction using an iCycler (Biorad, Hercules, CA) and pre-designed
TaqMan Gene Expression Assays (Applied Biosystems, Foster
City, CA). Cycle threshold values for RNA samples obtained from
triplicate cell samples were averaged; amounts of target were
interpolated from standard curves and normalized to the
housekeeping genes Hprt and Tbp.

RNA isolation and microarray hybridization
We established transcriptional profiles for UGE, UGM,
epidermis and dermis. Six replicates of UGE, five replicates of
UGM, four replicates of epidermis and four replicates of dermis
samples were analyzed. RNA was isolated by chloroform
extraction and precipitated using isopropanol. Additional column
purification was conducted (RNeasy mini kit, Qiagen, Valencia,
CA) and the resulting RNA treated to remove DNA contamination (DNAfree, Ambion, Austin, TX). RNA concentration was
assessed spectrophotometrically using a NanoDropH ND-1000
Spectrophotometer (Wilmington, DE). Protocols produced clean
RNA with OD 260/280.1.7. RNA quality was assessed using an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara,
CA). Samples with a RNA Integrity Number (RIN) .7.0 were
considered suitable for labeling and 20 ng were labeled using the
GeneChip two-cycle target labeling kit (Affymetrix, Santa Clara,
CA). Ten micrograms of labeled and fragmented cRNA were then
hybridized at 45uC for 16 h to the mouse genome MOE430 2.0
array (Affymetrix Santa Clara, CA) which interrogates ,45,000
transcripts. Raw expression data were analyzed using GCOS 1.4
(Affymetrix, Santa Clara, CA). Data were normalized to a target
2
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intensity of 500 to account for differences in global chip intensity.
The data discussed in this publication have been deposited in
NCBI’s Gene Expression Omnibus and are accessible through
GEO Series accession number GSE17797 (http://www.ncbi.nlm.
nih.gov/geo/query/acc.cgi?acc = GSE17797).

regulatory environment in the niche is likely to be due to specific
molecules contributed by either one compartment or the other
(Figure 1A).

A. Analysis of gene expression and definition of gene sets
Utilizing ArrayAssist (Stratagene, La Jolla, CA), raw Affymetrix
CEL files were processed by applying the MAS5 algorithm, to
assign detection calls (Present/Marginal/Absent) for each probe
set that were subsequently used in downstream data filtering. To
generate normalized expression levels, we used PLIER (probe
logarithmic intensity error) algorithm, a model-based, multi-array
signal estimator which produces more accurate probe-set signal
values [18]. The combination of these metrics was used for data
filtering to obtain 34,087 ‘‘valid genes’’, representing transcripts
(gene probes) with signals .20 and detected as Present in at least
one sample. A principle components analysis (PCA) (mean
centered) calculated over the entire list of valid genes by ArrayAssist,
shows an appropriate reproducibility and separation among the
different types of cells (Figure 1B). Notably, the first principal
component, that represents the greatest fraction of the variability
in the gene expression, separates the prostate-derived cells from
the skin-derived cells, while the second principal component,
representing the second greatest amount of information in the
expression data, discriminates between UGE/epidermis and
UGM/dermis samples. This indicates significant differences in
gene expression patterns between the tissue types. Thus the
patterns of the two epithelial tissues (UGE and epidermis) and the
two mesenchymal tissues (UGM and dermis) confirm similarities
in gene expression patterns between tissues derived from a related
ontogeny.
To define genes that were altered in a statistically significant
manner, the samples were grouped according to their site of origin
(UGE and UGM; epidermis and dermis), intensities of the valid gene
transcripts were log2-transformed and subjected to further
statistical analysis utilizing an unpaired t-test (Benjamini-Hochberg
corrected p,0.01) between the UGE and the UGM samples and
between the epidermis and the dermis samples. Two gene subsets
representing the genes that are differentially expressed between the
epithelial and the mesenchymal compartments were generated:

Analysis of functional categories
We utilized functional annotations of murine genes provided by
the Murine Genome Informatics, which uses the standard
vocabulary introduced by the Gene Ontology (GO) consortium.
Enriched functional categories (p#0.01, after correction for
multiple testing) were identified in each of the gene sets using
EXPANDER, in which hypergeometric calculation is used to
determine over-represented GO functional categories in a target
set relative to a background set (the entire collection of putative
murine genes) [17]. To avoid biases, genes represented by multiple
probe sets were counted only once.

Computational analysis of promoter cis-regulatory
elements
For promoter analysis we applied EXPANDER [17] to detect
cis-regulatory promoter elements that control the observed
transcriptional alterations in the gene expression clusters. Given
target and background sets of promoters, EXPANDER performs
statistical tests to identify TFs whose binding-site signatures are
significantly over-represented in the target set relative to
background (TF enrichment is indicated by p-value) [17]. Both
strands of each promoter were scanned for putative binding sites
(spanning the transcriptional start site from 1000 bp upstream to
200 bp downstream). The enrichments identified in this study
were robust, as they remained stable over a large range of
threshold values.

Results and Discussion
Isolation of urogenital sinus epithelium and its
mesenchyme
To identify the variations in gene transcripts in embryonic
UGE versus UGM we separated UGE and UGM cell populations
from 16-day-old murine embryos and isolated RNA from these
cells. In order to distinguish genes that are shared by other
developing epithelial/mesenchymal compartments in the embryo
from those that pertain to the prostate stem cell niche, we also
isolated RNA from the epidermis and dermis of the same
embryos. For each cell population we had at least 4 repetitive
samples (each sample was generated by pooling tissue from 20
embryos for UGE/UGM samples and from 15 embryos for
epidermis/dermis samples). The isolated RNA was processed and
prepared for hybridization to microarrays and analyzed as
described in Materials and Methods.
To reveal the genes that encode signaling molecules that may
participate in cellular interactions between these two compartments in the prostate stem cell niche, we based our analysis on the
genes that are differentially expressed between the UGE and the
UGM. These genes reflect those that are distinctively overexpressed by one of the compartments relative to the other. Defining
these differentially expressed gene transcripts may identify the
unique components that are provided by each of the compartments in the niche. It is important to note that the genes that have
similar expression levels in these two compartments (i.e., not
differentially expressed) are omitted from our analysis. It is possible
that these genes may encode regulators that contribute to signaling
in the niche. We however focused our observations on the
differentially expressed genes as we consider that the primary
PLoS ONE | www.plosone.org

(1) a ‘‘prostate’’ subset containing 5,631 transcripts whose
expression was altered (up or down-regulated .2-fold)
between the UGE and UGM samples and
(2) a ‘‘skin’’ subset containing 4743 transcripts whose expression
was altered (up or down-regulated .2-fold) between the
epidermis and dermis samples (Figure 1C, Tables S1, S2).
We determined if we could discern common expression patterns
shared between these two subsets and patterns that were unique to
the prostate stem cell niche subset. Intersection of the two subsets
resulted in the generation of three clusters (Prostate-only, Prostate+
Skin and Skin-only) of mutually or exclusively expressed genes
(Figure 1C). A distinct transcriptional expression pattern derived
from the prostate stem cell niche cell population is manifest by
3,062 transcripts that are exclusively altered in the prostate stem
cell niche (Prostate-only cluster). A smaller distinct pattern was
evident in the skin cell populations represented by 2,174
transcripts (Skin-only cluster). This implies that the prostate niche
has a greater number of genes that are differentially expressed
between the epithelial and the mesenchymal compartments than
noted in the skin compartment. This indicates that the unique
transcriptional program that regulates the cellular signaling of the
prostate stem cell niche may be more complex than the
transcriptional program that regulates the molecular interactions
3
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shown. The pattern is indicative of good separation of the four
populations and good reproducibility within the replicate samples of
each group. Each group is designated by a different color. C. Venn
diagram detailing the number of transcripts (gene probes) shared and
distinct among prostate and skin subsets. The numbers of transcripts
within each subset is given in brackets outside the Venn chart (Prostatesubset (5631 transcripts); Skin-subset (4743 transcripts)). The numbers
of transcripts within each cluster (Prostate-only, Prostate+Skin and Skinonly) are given in Italics adjacent to each arrowhead. The number of
transcripts within the epithelial and mesenchymal compartments of
each cluster (i.e., the gene sets) are depicted inside the slices of the
Venn chart.
doi:10.1371/journal.pone.0013024.g001

in the epidermis/dermis. Interestingly, within the cluster that
overlaps between the prostate stem cell niche and the epidermis/
dermis subsets, the Prostate+Skin cluster, we found a substantial
number of transcripts (2,569) whose differential expression is
altered in both the prostate and epidermis/dermis subsets
(Figure 1C). These data indicate that approximately half of the
differentially expressed transcripts of the prostate and skin
epithelial/mesenchymal subsets are shared while the remaining
half represent a unique group of transcripts whose gene expression
is specifically altered either in the prostate or in the skin.
To further analyze global transcriptional patterns that pertain to
primitive prostate and skin epithelial/mesenchymal subsets, we
determined the epithelial and the mesenchymal transcripts that are
up-regulated in each of the three clusters. In the Prostate-only cluster
we identified 1,634 transcripts (Prostate-only UGE gene set) that are
differentially overexpressed in the UGE relative to the UGM (.2fold) and 1,428 transcripts (Prostate-only UGM gene set) that are
differentially up-regulated in the UGM over the UGE. In the Skinonly cluster we identified 654 transcripts (Skin-only epidermis gene set)
that are differentially increased in the epithelium over the dermis
and 1,520 transcripts (Skin-only dermis gene set) that are differentially up-regulated in the dermis over the epidermis (Figure 1,
Table S3). In the common cluster (Prostate+Skin cluster, which
contains 2,569 common altered transcripts) our analysis identified
2,445 transcripts that have a common regulation pattern shared by
both the epithelial compartment and the mesenchymal compartment of both the prostate and skin epithelial/mesenchymal
subsets; 744 transcripts of this cluster were up-regulated in both
the UGE and the epidermis (Prostate+Skin UGE/epidermis gene set)
relative to the UGM or the dermis, whereas 1,701 transcripts were
up-regulated in both the UGM and the dermis (Prostate+Skin
UGM/dermis gene set) relative to the UGE or the epidermis
(Figure 1, Table S3). This indicates that the majority of the
genes of the Prostate+Skin cluster (2445/2569; .95%) share a
common regulatory pattern within their respective epithelial or
mesenchymal compartments.

B. Functional and promoter sequence analysis of gene
expression in the prostate stem cell niche
By analyzing the Prostate-only cluster and the Prostate+Skin and
Skin-only clusters we were able to determine attributes that are
unique to prostate and those that are shared by both prostate and
skin. The Prostate-only cluster reflects a unique cohort of genes that
are important for regulating the dynamics and interactions in the
prostate stem cell niche. Analysis of the two gene sets of this
cluster, Prostate-only UGE and Prostate-only UGM gene sets, indicates
commonalities in functional categories and promoter TF-binding
motifs between these two gene sets (Table 1, Tables S4, S5).
Functional categories which reflect expected features of stem cell
biology are anatomical structure development and cell adhesion [19] and
epidermis development, ion channel activity and calcium ion binding [20,21].

Figure 1. Definition of gene sets that are differentially
expressed in the prostate stem cell niche. A. Genes that were
differentially expressed by more than 2-fold in each compartment
versus the other were selected for analysis of enriched functional
categories, TF-binding motifs and ligand-receptor interactions. The line
sloping down represents UGE vs UGM expression levels and the line
sloping up represents UGM vs UGE expression levels. B. A plot of the
principal components analysis (PCA) of differentially expressed gene
sets derived from epithelial and mesenchymal compartments of the
prostate and the skin. Expression data from the ‘‘valid genes’’ used in
our analysis were subjected to PCA mapping. The positions of the
samples with respect to the first two Eigenvectors (E1 and E2) are

PLoS ONE | www.plosone.org
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Table 1. Functional and promoter sequence motifs overrepresented within the Prostate-only cluster in the UGE and UGM
compartments.

Functional category
enriched in UGM

Gene Ontology
ID

Genes
associated
with the
category

128

anatomical structure
development

0048856

136

136

multicellular organismal
development

0007275

147

Functional category
enriched in UGE

Gene Ontology
ID

Genes
associated with
the category

anatomical structure
development

0048856

multicellular organismal
development

0007275

cell adhesion *

0007155

51

cell adhesion *

0007155

51

regulation of cellular
process

0050794

192

ion channel activity

005216

49

epidermis development

008544

21

extracellular space

000561

49

intracellular signaling
cascade *

0007242

78

cell soma

0043025

15

ion channel activity

005216

49

extracellular space

000561

49

cell soma

0043025

15

membrane fraction

0005624

43

calcium ion binding

0005509

63

cytoskeleton organization 0007010
and biogenesis

40

cytoplasmic vesicle

00431410

25

Accession
number in
TRANSFAC

p-value**

TF enriched in UGE

Accession
number in
TRANSFAC

p-value**

Enrichment
factor ***

TF enriched in UGM

Ap2 *

M00915

2.2E-05

1.3

Ap2 *

M00189

3.5E-06

1.3

E2f *

M00803

8.0E-05

1.2

E2f *

M00803

3.8E-07

1.2

Lbp1 *

M00947

2.3E-07

1.4

Lbp1 *

M00644

8.4E-06

1.2

Sp1 *

M00196

2.8E-11

1.3

Zf5 *

M00716

2.0E-08

1.2

Areb6

M00414

2.5E-08

1.5

Lmo2 complex

M00277

1.5E-06

1.4

Hen1

M00058

1.8E-05

1.4

Nrsf

M00256

2.6E-06

1.4

Maz *

M00649

2.3E-05

1.4

Etf

M00695

2.3E-05

1.2

TFII-I

M00706

3.6E-06

1.4

Enrichment
factor ***

*Categories that are also enriched in the corresponding skin compartments.
**p values indicate the significance of TF signature enrichment in the gene set relative to that in the background set as described in Materials and Methods.
***Enrichment factor values represent the frequency of the TF signature in a cluster divided by its frequency in the background set.
doi:10.1371/journal.pone.0013024.t001

The unique cohort of genes that are represented exclusively in the
epidermis/dermis (Skin-only cluster) are defined by several features
that also define the unique genes of the prostate (Table 1 - these
categories are denoted by an asterisk). The important characteristic of the stem cell niche of providing physical contact [22] is
indicated by the category cell adhesion (Table 1). In addition, many
TF-binding motifs are shared between these two unique clusters.
This suggests that even though each of these cell populations has a
unique cohort of transcripts that defines almost half of its cellular
signaling program, a common set of TFs may coordinate their
individual transcriptional programs.
Under the assumption that gene expression levels correlate with
the level of their encoded proteins, the UGM compartment
manifests a greater signaling complexity (indicated by its increased
number of enriched functional categories) than the UGE
compartment (Tables 1, 2). This may reflect the role of the
UGM in defining the appropriate signals that are essential for
supporting and regulating the behavior of the primitive stem cells
PLoS ONE | www.plosone.org

in their niche [7,23]. It could also reflect the more heterogeneous
cell population of the mesenchyme. A number of categories that
are expressed in the Prostate+Skin UGM/dermis gene set (e.g. organ
morphogenesis, cell proliferation, response to external stimulus and cell
migration) (Table 2) may be involved in the supportive role the
mesenchymal compartment plays in providing the appropriate
microenvironment for the primitive epithelial compartments of the
prostate and skin. A variety of functional categories such as
sialyltransferase activity [24], carbohydrate binding [25], receptor tyrosine
kinase activity [26] and collagen [27,28] that are significant to the
biology of stem cells are also enriched in the Prostate+Skin UGM/
dermis gene set.
The promoter sequence analysis indicates that some of the
enriched binding motifs are shared by gene sets of the prostate and
the skin, among them the binding site of TFII-I, Srebp1, Maz and
Lmo2 (Tables 1, 2). This indicates the central role that these TFs
may play in the regulation of epithelial/mesenchymal niche
interactions.
5
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Table 2. Functional and promoter sequence motifs overrepresented within the Prostate+Skin cluster of UGE/epidermis and
UGM/dermis.

Functional category
enriched in UGE/
epidermis

Gene Ontology
ID

Genes
associated
with the
category

Functional category
enriched in UGM/dermis

Gene Ontology
ID

Genes
associated
with the
category

plasma membrane

005886

50

plasma membrane

0005886

161

anatomical structure
development

0048856

70

proteinaceous extracellular
matrix

0005578

84

intracellular signaling
cascade

0007242

46

multicellular organsimal
development

0007275

243

morphogenesis of
epithelium

0002009

13

cell adhesion

0007155

114

cytoskeleton

0005856

38

calcium ion binding

0005509

113

kinase activity

0016301

40

cell migration

0016477

61

phosphorus metabolic
process

0006793

36

organ morphogenesis

0009887

78

blood vessel development

0001568

47

nervous system development

0007399

80

phosphate transport collagen

0005581

19

enzyme linked receptor protein 0007167
signaling pathway

43

carbohydrate binding

0030246

42

regulation of cellular process

0050794

263

tube development

0035295

26

response to external stimulus

0009605

48

cytoskeletal protein binding

0008092

40

ion transport

0006811

64

negative regulation of
biological process

0048519

75

transmembrane receptor protein 0005624
tyrosine kinase activity

15

cell proliferation

0008283

45

sialytransferase activity

0008373

8

myofibril

0030016

15

intracellular signaling cascade

0007242

79

actin cytoskeleton

0015629

25

Accession
number in
TRANSFAC

p-value*

TF enriched in UGE/
epidermis

Accession
number in
TRANSFAC

p-value*

Enrichment
factor **

TF enriched in
UGM/dermis

Sp1

M00196

1.1E-17

1.4

Sp1

M00196

7.8E-05

1.1

TFII-I

M00706

9.6E-05

1.4

TFII-I

M00706

3.5E-05

1.3

Srebp1

M00749

8.9E-05

1.4

Srebp1

M00749

4.5E-05

1.3

Enrichment
factor **

Lmo2 complex

M00277

7.1E-10

1.8

Mazr

M00491

5.0E-13

1.5

Areb6

M00414

8.9E-10

2.0

Maz

M00649

5.1E-12

1.4

Egr1

M00807

2.8E-07

1.4

Lbp1

M0644

4.4E-08

1.3

E2a

M00804

2.9E-05

1.5

Ap2

M00915

5.9E-07

1.3

Rreb1

M00257

8.4E-07

1.3

Spz1

M00446

4.6E-06

1.4

Pax4

M00378

1.0E-05

1.3

Lbp1

M00947

1.0E-05

1.3

Zf5

M00716

1.9E-05

1.2

Hen1

M00058

2.2E-05

1.3

Smad

M00974

9.6E-05

1.4

*p values indicate the significance of TF signature enrichment in the gene set relative to that in the background set as described in Materials and Methods.
**Enrichment factor values represent the frequency of the TF signature in a cluster divided by its frequency in the background set.
doi:10.1371/journal.pone.0013024.t002
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Additional support for self-renewal in the prostate stem cell
niche is indicated by Ap2 (Table 1) that promotes proliferation
over differentiation and is a marker of stemness and pluripotency
[38]. Ap2 regulates basal progenitor fate in a region- and layerspecific manner in the developing cortex as its deletion during
development results in a specific reduction of upper layer neurons
in the occipital cortex, leading to impaired function and enhanced
plasticity of the adult visual cortex [39]. Recently, a ChIP-chip and
transcriptome study of transcriptional networks testing TFoccupancy of genes involved in trophoblast stem cell self-renewal
has shown that Ap2 along with four other genes occupies gene
promoters involved in maintaining the stem cell phenotype and
pluripotency [40]. We find that the transcript levels of three
members of the Ap2 gene family are altered in the prostate stem
cell niche. The mRNA levels of Tcfap2a and Tcfap2c are higher in
the UGE compared with the UGM by 3- and 10-fold respectively,
while transcript levels of Tcfap2b are 6-fold higher in the UGM
(Table S1). qPCR analysis validated the expression of Tcfap2c,
indicating that it is significantly elevated in the UGE (11-fold)
relative to the UGM (Figure 2). The transcription factor TFII-I
(Table 1) restricts the expression of b-globin to the adult stage of
erythropoiesis thus maintaining the primitive phenotype of murine
embryonic stem cells [41]. In addition, the enrichment of the
Smad motifs are in agreement with the known regulatory role of
the TGF-b pathway in maintaining the primitive phenotype of
embryonic stem cells [42] and in promoting quiescence of adult
prostate cells [43,44]. In this regard, it is important to note that the
TGF-b pathway plays an important role in the activity of TFII-I
proteins. In MCF7 breast tumor cells TGF-b-dependent phosphorylation of TFII-I results in reduced transcriptional activation
of Ccnd2, Ccnd3 and E2f2 genes [45]. However, the addition of
TGF-b to mouse P19 embryonal carcinoma cells induces
transcription of TFII-I [46].
b) Regulation of lipid metabolism. Several findings
support the notion that lipid metabolism plays a major role in
the prostate stem cell niche. The binding motif of the sterol
regulatory element-binding factor 1 (Srebp1/Srebf1), an
androgen-regulated TF with a role in the metabolism of lipids
[47], is apparent in Prostate+Skin UGE/epidermis and Prostate+Skin
UGM/dermis gene sets (Tables 2, 3). In addition, Srebp1 mRNA is
up-regulated by 3-fold in UGE relative to the UGM (Table S1).
Analysis by qPCR confirms that Srebp1 is up-regulated by 3-fold in
the UGE cells compared with the UGM cells (Figure 2). Recent
studies indicate that lipids have an important role in the selfrenewal of stem cells [48,49]. A recent study has shown that
embryonic stem cells are characterized by highly unsaturated lipid
metabolites that are important in maintaining ‘chemical plasticity’
and ultimately in mediating pluripotency. Inhibition of a prooxidative cascade that oxidizes highly unsaturated lipids promotes
the pluripotent state of embryonic stem cells and inhibits
differentiation [50]. Srebp1 contributes to the androgenindependent survival and proliferation of prostate cancer cells
[51]. In addition, prostate tumors have an innate capacity to
synthesize androgen from cholesterol [52], indicating the
relevance of lipid metabolism for both normal stem and prostate
tumor cell biology. In agreement with this, we note the enrichment
of the functional category plasma membrane in two of the
Prostate+Skin UGE/epidermis and Prostate+Skin UGM/dermis gene
sets (Table 2). Genes that are specifically involved in lipid
metabolism such as Anxa7 are up-regulated in the UGE (3-fold)
while others, such as PrnP, Syt1 and Dgkb are highly expressed (4, 8
and 8-fold, respectively; Table S1) in the UGM. In this regard,
fatty acids regulate gene expression and significantly stimulate the
growth of human prostate cancer PC-3 cells [53]. Furthermore,

C. The potential regulatory layers of gene expression in
the prostate stem cell niche
Our analysis reveals that several TFs are potentially active in
both the UGE and the UGM. Of interest is the finding that several
TFs that may be active in the prostate stem cell niche may also be
operative in the skin compartment. Ample evidence (see below)
indicates that many of these TFs have central regulatory roles in
controlling gene expression in other stem cell systems where they
regulate functions such as self-renewal, migration and oncogenesis.
a) Self-renewal and maintenance of primitive cells. The
enrichment of several TF-binding motifs in genes that are
overexpressed in the prostate stem cell niche supports the notion
that this is a self-renewing primitive compartment (Table 3).
Expression of E2f (Table 1) is associated with the self-renewal of
murine trophoblast stem cells [29], the expansion of stem cells in
the columella and lateral root caps of Arabidopsis [30] and with
poor prognosis in prostate cancer [31] Recently, genomic profiling
indicated the functional role of the Rb-E2F axis in controlling
quiescence in adult murine hair follicle bulge stem cells [32]. In
addition, studies on impaired wound healing in E2F1-null mice,
due to defective cell proliferation and thus reduced reepithelialization, strengthen the role of E2F in the maintenance
of proper stem cell self renewal in the epidermis [33]. Lastly, nextgeneration sequencing (ChIP-Seq) revealing binding patterns of
twelve TFs that govern the regulation of differential gene
expression in embryonic stem cells, has identified E2F1 as an
activator that induces up-regulation of genes that allow
maintenance of self-renewal and pluripotency [34].
Etf/Tead2 (Table 1) promotes self-renewal of progenitor cells
in the olfactory epithelium [35] and is an essential transcriptional
regulator during the first week of murine embryo development
[36]. In addition, Tead2 may be involved in the production or
maintenance of embryonic stem cells as comprehensive transcriptional profiling shows that Tead2 is highly expressed in embryonic,
neural and hematopoietic stem cells [37]. Since these analyses
compared the transcript levels of proliferating stem cells relative to
differentiated cells, the expression of Tead2 appears to be specific
to proliferating cells suggesting a possible role in self-renewal of
embryonic prostate stem cells.

Table 3. Transcription factors involved in the biology of the
prostate stem cell niche.

Category

Transcription Factor

Self-renewal and maintenance of
primitive cells

E2f
Etf/Tead2
Ap2
TFII-I
Smad

Lipid metabolism
Migration and tumorigenicity

Srebp1
Lmo2
Egr1
Areb6/Zeb1
Rreb1

Neuronal lineage

Hen1/Nscl1/Nhlh1
Nrsf/Rest

doi:10.1371/journal.pone.0013024.t003
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Figure 2. Transcript level of unique markers of the prostate UGE and UGM. Microarray data (white columns) of unique markers of the
prostate niche are expressed as the fold change of mRNA levels of the UGE vs the UGM [mean6SD; n = 6]. Results of real-time quantitative PCR
analysis (qPCR) (black columns) are presented as the fold change of transcripts after normalization of UGE vs UGM [mean6SD; n = 3].
doi:10.1371/journal.pone.0013024.g002

inhibition of fatty acid synthase parallel to reduction of
endogenous lipid synthesis induced by the green tea component,
Epigallocatechin-3-gallate, leads to selective induction of apoptosis
in prostate cancer cells [54]. In addition, several genes related to
phospholipid metabolism such Tiam1, Mdr3/Abcb1a, Lgals and
Dlk1, Pltp and Akp2 are up-regulated in both adult and fetal
prostate stem cells [43]. The contribution of this group of genes to
the stem cell niche may be especially significant because proteins
active in signaling pathways of stem cells (e.g., Wnt proteins) are
known to undergo lipid modification that regulates their ability to
maintain stemness [55].
c) Promotion of migration and tumorigenicity. Several of
the TF-binding motifs that are enriched in the prostate stem cell
niche are implicated in the development of prostate cancer
(Table 3). Binding motifs of the LIM domain only 2 (Lmo2) are
enriched in Prostate-only UGM and the Prostate+Skin UGE/epidermis
gene sets (Tables 1, 2) and the transcript level of Lmo2 is 11-fold
higher in the UGM relative to the UGE (Table S1). In normal
prostate, Lmo2, a regulator of cell fate and differentiation, was
shown to be expressed exclusively in the basal cell layer [56]. In
addition, overexpression of Lmo2 is significantly associated with
the advanced stage of human prostate tumors and stable
expression of LMO2 in LNCaP cells promotes cell motility and
invasiveness in vitro [57]. Abundant evidence indicates that the
early growth response-1 protein (Egr1) has a role in prostate
cancer [58,59,60]. The increased activity of Egr1 (Tables 2, 3)
was recently found to promote the growth of prostate cancer cells
in an androgen-depleted environment [61], suggesting that
prostate tumor cells may adopt regulatory pathways expressed in
prostate stem cells. In support of this finding, down-regulation of
Egr-1 by siRNA inhibits PC-3 human prostate tumor growth and
PLoS ONE | www.plosone.org

induces apoptosis [62]. In addition, E2F1 induces tumor cell
survival and promotes resistance to drug-induced apoptosis via
induction of Egr1 transcription in the human prostate cell lines
DU145 and PC3 [63].
Enrichment of Areb6/Zeb1 motifs in both the Prostate-only UGE
and the Prostate+Skin UGE/epidermis gene sets suggests that cell
migration may be an integral component of the prostate stem cell
niche. This TF is a regulator of epithelial-mesenchymal transition
in prostate cancer and stimulates migration and invasion of
prostate cancer cells [64]. Interestingly, epithelial-mesenchymal
transition has been shown to generate cells with properties of stem
cells [65]. The activity of Areb6 in the prostate stem cell niche may
be related to this process in the primitive niche as well as to the
invasion of the epithelial stem cells into their surrounding
mesenchyme to form the primitive prostate buds from which the
prostatic ducts develop [11]. Another regulator that may affect cell
migration in the prostate stem cell niche is Rreb1 (Table 3) that
suppresses AR-mediated promoter activity in prostate cancer cells
[66]. In addition, Rreb1 is essential for diminishing the cell-cell
adhesive interactions of epithelial cells and is required for their
migration [67]. Thus, the combination of transcription factors
expressed in the primitive prostate stem cell niche may dictate the
dynamic changes in morphology and migration of cells within
their niche.
d) Expression of neuronal lineage markers in the prostate
stem cell niche. Our analysis also identifies cellular regulators

that may be related to the neuronal lineage. The Prostate-only UGE
and Prostate+Skin UGM gene sets are both enriched in the Hen1/
Nscl1/Nhlh1 binding motif. Hen1 is a neural cell-specific TF that
is expressed in cells in the developing pons in the embryonic
murine brain. It orchestrates the migration of neuronal precursor
8
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metabolism and the Wnt signaling pathway are both important
regulators in the prostate stem cell niche.
The Wnt/b-catenin pathway also regulates the expression of
members of the family of Eph receptors and their ephrin ligands
[75]. Eph-ephrin interactions are responsible for positioning cells in
the stem cell niche and promote proliferation of progenitor cells
[76]. Several ligands and receptors of this family are highly
expressed in the epithelial and in the mesenchymal compartments of
the prostate stem cell niche (Table 4, Figures 2, 3). Specifically,
qPCR analysis indicates a 3-fold increase in the Efna1 ligand in the
UGE and a 11-fold increase in expression of the ephrin receptor
Epha3 in the UGM (Figure 2). Ephrin ligands and their receptors
may have clinical relevance as their expression pattern differs
between normal prostate epithelium and prostate carcinomas [77].
Notably, expression of two ephrin receptors that are present in the
prostate stem cell niche, Epha1 and Epha3, is decreased in prostate
cancer compared with the normal tissue [77].
An additional ligand-receptor pair that is expressed in the
prostate stem cell niche (Table 4) and interacts with the Wnt/bcatenin pathway is that of platelet derived growth factor (PDGF)
and its receptor. Up-regulation of b-catenin, induced by PDGF,
promotes the formation of a multipotent bone marrow-derived
mesenchymal stem cell niche [78]. PDGF induces epithelialmesenchymal transition in prostate cancer PC3 cells, promotes
tumor growth and contributes to the ‘‘cancer stem-like’’ phenotype
associated with epithelial-mesenchymal transition [79]. This ligand
and its receptor may therefore be important regulators of stem cell
behavior in the prostate stem cell niche.
Another major signaling pathway that is relevant to embryonic
and postembryonic stem cell biology is the Notch pathway [80]
that is represented in the prostate stem cell niche by several ligandreceptor candidates whose level is differentially expressed in one of
the niche compartments (Table 4). For example, the UGE
compartment expresses increased levels (4-fold) of the Notch
ligand, Jag2, while the UGM cells express relatively high levels (4fold) of another family ligand, Notch4 (Figures 2, 3). This pathway
is important for the early development of the prostate and for
branching morphogenesis [81,82]. Inhibition of Notch signaling
leads to dramatic alteration in prostatic morphogenesis, including
increased budding and epithelial proliferation. In addition,
expression of Notch1 is significantly lower in human prostate
carcinoma compared to normal tissues [81,82]. This indicates that
abrogation of the inhibitory effect of Notch signaling in the niche
may promote the expansion of primitive cells, thus facilitating
evolution of prostate tumors.
Fibroblast growth factor (FGF) signaling has a major role in the
self-renewal of human embryonic stem cells [83,84] and is
essential for the maintenance of their supportive niche [85].
Members of the FGF family also participate in mesenchymal/
epithelial interactions during organogenesis and carcinogenesis.
Impaired FGF signaling promotes epithelial-mesenchymal transition and tumor progression in murine prostate cancer models [86].
Fgfr2 is important for prostatic branching morphogenesis and for
acquisition of androgen responsiveness in mice [87]. Our analysis
for genes participating in ligand-receptor interactions reveals an
abundance of FGF family members that may participate in the
regulation of this pathway (Table 4, Figure 3). An important
indication of the role of FGF signaling in the prostatic stem cell
niche is the finding that enhanced mesenchymal expression of
Fgf10 promotes multifocal intraepithelial neoplasia lesions in the
prostate. Furthermore, inhibition of epithelial Fgfr1 signaling leads
to reversal of the cancer phenotype, suggesting that stromal Fgf10
expression promotes the multifocal formation of prostate carcinoma [13].

cells and also inhibits apoptosis thus promoting their survival [68].
Another TF binding motif that is active in the neuronal lineage is
Nrsf/Rest. This TF maintains self-renewal and pluripotency,
preventing differentiation in embryonic [69] and neuronal stem
cells [70]. In contrast to TFs that induce expression of their target
genes, Nrsf is a transcription repressor and thus its repressive
activity down regulates its target genes. Therefore, the enrichment
of its binding motif in the UGM implies that these genes are
relatively highly expressed in the UGM as a result of the
suppressive activity of Nrsf in the UGE (Table 1). For example,
the expression of Synapsin1 transcripts, an Nrsf-suppressed target
gene, is 7-fold lower in the UGE relative to the UGM (Table S1).
Our functional analysis supports these observations as one of the
categories that is enriched in the Prostate+Skin UGM/dermis gene
set, nervous system development, is related to the neuronal lineage
(Table 2). These data indicate that the neuronal and prostate
stem cell niches may have a number of commonalities.
Interestingly, the molecular signature of adult prostate stem cells
indicates that it resembles that of neuronal or embryonal
progenitors to a greater extent than that of hematopoietic
progenitors indicating some commonalities with the neuronal
lineage [43]. It is also possible that neuronal progenitor cells may
be present within the UGM and dermal compartments.

D. Ligand – receptor interactions in the prostate stem cell
niche
One of the major cellular mechanisms by which stem cells
convey signals within their niche is via ligand-receptor interactions. Both the identity of the specific ligand-receptor interaction
as well as its quantitative nature have a significant effect on stem
cell fate [71]. We therefore used our differential gene expression
profiling data to obtain insights into the ligand-receptor interactions that may mediate signals between the UGE and UGM in the
prostate stem cell niche. We identified two types of ligand-receptor
interactions that, based on the differential gene expression profiles
in UGE/UGM, could potentially be active in the embryonic
prostate stem cell niche:
(1) paracrine interactions in which the receptor is expressed by
one of the compartments while the ligand is expressed by the
corresponding compartment (e.g., UGE-ligand and UGMreceptor or vice versa) and
(2) autocrine interactions in which both the ligand and the
receptor are expressed by the same compartment (e.g., UGEligand and UGE-receptor) (Table 4).
This survey indicates that some of the predicted ligand-receptor
interactions identified in the prostate stem cell niche (Figure 3)
are also present in the epidermis/dermis compartment (Table 4,
indicated by an asterisk). The Wnt/b-catenin pathway that
promotes self-renewal in various types of stem cells, such as
keratinocytes, embryonal, colon, intestinal and follicular stem cells
[72], has the greatest ligand-receptor representation in the prostate
stem cell niche (Table 4). For example, Wnt5a expression is 6-fold
higher in the UGM compared to the UGE (Figure 2). In the bone
marrow niche this signaling pathway is essential for maintaining
the quiescent state of hematopoietic stem cells [73]. Activating
mutations and overexpression of numerous components of the
Wnt/b-catenin pathway are present in patients with advanced
prostate tumors [74], indicating that these tumors may arise in the
primitive compartment. As mentioned above, lipid modification
plays a major role in Wnt signaling, as these proteins require
palmitoylation for their activity [55], indicating that lipid
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Table 4. Ligand-receptor pairs whose transcripts are up-regulated in UGE and UGM.

Category

UGE ligand

UGM receptor

UGM ligand

UGE receptor

Wnt signaling

Wnt4 (x23)*

Fzd1 (x4)

Wnt2 (x12)*

Fzd6 (x6)*

Wnt6 (x6)

Lrp8 (x3)

Wnt5a (x6)*

Lrp2 (x4)

Wnt7b (x13)

Lrp11 (x11)

Wnt5b (x4)

Lrp4 (x2)

Wnt10a (x15)

Paracrine
and
autocrine
signaling

Wnt9a (x5)*
Wnt11 (x8)

Notch signaling

Ephrin signaling

Jag2 (x4)

Efna1 (x3)

Notch4 (x4)*

Epha3 (x9)*

Dll1 (x2)

Notch1 (x4)*

Dlk1 (x4)*

Notch3 (x4)

Efna2 (x3)

Epha4 (x5)

Epha1 (x8)*
Epha2 (x4)

Epha5 (x12)
Epha7 (x4)
Ephb1 (x13)

Efnb1 (x2)

Ephb6 (x2)

Efnb3 (x6)*
Fibroblast growth factor signaling

Fgf1 (x4)

Fgfr1 (x3)*

Fgf14 (x2)

Fgfr2 (x3)

Fgf13 (x4)*

Fgfr3 (x21)*

Fgf7 (x4)*
Inhibin signaling

Inha (x2)*

Inhba (x16)

Acvr1b (x3)*
Acvr2b (x2)

Bone morphogenetic protein family

Bmp4 (x12)*

Bmpr1b (x2)

Bmp5 (x5)*

Acvr2b (x2)

Bmp6 (x2)
Hedgehog signaling

Shh (x34)

Ptch1 (x3)
Ptch2 (x4)

Neurotrophic tyrosine kinase

Ntrf5 (x3)

Ntrk2 (x9)*

Ngfb (x2)

Ntrk3 (x8)

Ntf3 (x3)

Ngfr (x17)*
Platelet-derived growth factor
Tgf-beta signaling

Pdgfa (x6)

Pdgfra (x11)*
Tgfbr2 (x5)*

Tgfb2 (x5)*

Eng (x3)

Tgfb3 (x11)*

Autocrine
signaling

Ltbp1 (x2)
Angiogenesis signaling

Tek (x7)*

Angpt1 (x14)*
Angptl1 (x7)*

Kdr (x14)*

Vegfc (x6)
Flgf (x4)*

Flt1 (x6)*

pgf (x4)

Nrp1 (x6)*
Protein tyrosine phosphatase

Ptprz1 (x6)

Ptn (x4)*

Ptprb (x10)*
*Ligand or receptor transcripts that are also overexpressed in the epidermis/dermis.
doi:10.1371/journal.pone.0013024.t004

TGF-b and BMPs, that are members of the TGF-b superfamily,
also initiate pathways that are highly relevant in maintaining stem
cell self-renewal [42,88]. A number of these molecules are
overexpressed in the UGE and UGM (Table 4, Figure 3).
TGF-b signaling has a central role in mediating epithelialmesenchymal interactions within the adult prostate stem cell
niche [44]. The loss of the TGF-beta type II receptor gene in
PLoS ONE | www.plosone.org

murine stroma results in intraepithelial neoplasia in prostate and
an increased abundance of stromal cells [12,89].
Other potential stem cell related ligand-receptor pairs that are
identified by our survey in the prostate stem cell niche belong to
the Shh-signaling pathway. This pathway induces proliferation of
primitive human hematopoietic stem cells [90]. Shh-signaling is
important for normal prostate growth and increases during
10
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Figure 3. The signal transduction pathways expressed in the prostate stem cell niche. Ligand-receptor interactions and transcription
factors that are differentially expressed between the UGE and the UGM are depicted. These are the main mediators of the cellular cross-talk between
these two compartments in the prostate stem cell niche. These mediators include members of the Shh, Wnt/b-catenin, Notch, FGF and TGF-b
signaling pathways that are important regulators of stem cell self-renewal and differentiation. Transcriptional regulators whose binding motifs are
enriched in the differentially expressed genes are depicted in the nucleus. Activation of these transcription factors promotes expression of genes that
are involved in self-renewal, lipid metabolism and cell migration. Many of these factors are implicated in the progression of prostate tumors as their
expression is increased (e.g., Wnt/b-catenin genes) or decreased (e.g., Notch genes).
doi:10.1371/journal.pone.0013024.g003
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development of prostate tumors that have increased expression of
progenitor cell markers [91,92], implying that primitive cells with
an active Shh pathway may be expanded during tumorigenesis.
The increased expression of the receptor for Shh, Ptch1, was
confirmed by qPCR to be increased by more than 2-fold in the
UGM compared to the UGE (Figure 2).
The Tek (Tie2)/angiopoietin1 signaling pathway that regulates
hematopoietic stem cell quiescence in the bone marrow niche [93],
is another pathway whose members are present in the prostate
niche (Table 4). Plasma levels of the soluble Tek receptor are
elevated in prostate cancer patients [94]. Expression of angiopoietin-2, the antagonist of angiopoietin-1, correlates with severity
of disease in prostate cancer [95], suggesting that interference with
the angiopoietin-1-Tek interaction may disrupt stem cell homeostasis.

niche may be accomplished by paracrine interactions resulting
from the expression and secretion of Shh by the UGE and its
binding to the Ptch1 receptor, expressed by the UGM (Figure 3).
In this regard, it is important to note that some of the postulated
ligand-receptor interactions that we are proposing in the prostate
stem cell niche could also be shared by other primitive niches, as
we find similar differential expression of a number of these genes
in embryonic skin (Table 4). For example, some of the Wnt
pathway genes, such as Fzd6, Wnt2 and Wnt4, are also
differentially expressed by the embryonic dermis and epidermis.
There are however genes belonging to signaling pathways such as
Ephrin and Shh whose differential expression is confined to the
prostate stem cell niche (Table 4).
As we are aware of no transcriptional or protein expression
data from other mammalian stem cell niches, a comparison
between the prostate stem cell niche and other primitive niches
can not be made. However, we expect that the detailed
transcriptional profiles of the epithelial and the mesenchymal
compartments of the embryonic prostate stem cell niche will be a
useful source of data for such comparisons in the future. We
should note, however, that some of the gene expression
differences described in this study may be associated with more
general epithelial-mesenchymal interactions rather than specific
niche interactions. Future studies will determine protein
expression by differentially expressed transcripts in the embryonic prostate stem cell niche. The expression of interesting
proteins will be examined during fetal prostate development as
well as in the adult prostate. As stem cells in the adult prostate
reside in the proximal regions of ducts the proximal–distal
prostate axis will be examined for evidence of differentially
expressed molecules. This would indicate similarities between
the adult and the fetal stem cell niches. As many of the
interactions that regulate growth and differentiation in the
normal adult prostate stem cell niche may also be involved in the
aberrant proliferation of niche cells, their elucidation may
provide insight into mechanisms subverted during abnormal
proliferative events that result in benign prostate hyperplasia and
prostate carcinoma. Importantly, it has been noted that prostate
tumors originate in the stem cell enriched proximal region of
prostatic ducts [9].

E. Integrin expression in the prostate stem cell niche
Integrins mediate attachment of stem cells to the matrix in the
niche. Interaction of integrins with their matrix initiates signaling
pathways and can also activate growth factor receptors [96]. In the
UGM we find an increase of Itga1 (4-fold), Itga4 (13-fold), Itga7 (2fold), Itga8 (3-fold), Itga9 (4-fold) and Itgb3 (2-fold). (Table S1).
A number of transcripts for other integrins implicated in stem
cell biology and prostate cancer are up-regulated in the UGE. The
a3 (Itga3) (up-regulated by 3-fold in the UGE) and b1 integrin
subunits pair to form the a3b1 (VLA3) complex and the a6 and b4
(Itgb4) (up-regulated by 10-fold in the UGE) (Table S1) subunits
pair to form the a6b4 complex, both of which are expressed in
keratinocyte stem cells [96] and function as receptors for laminin,
a major component of the basement membrane. The expression of
the a3 integrin subunit is significantly increased by p63 [97].
Expression of Trp63 is up-regulated 32-fold in the UGE relative to
the UGM (Table S1). This may be responsible for the elevated
expression of the transcript for the a3 integrin subunit in the UGE
[97] which may influence the attachment of prostate stem cells to
their niche. Interestingly, the transcript for integrin b6, an
epithelial specific integrin [98] that is up-regulated 5-fold in the
UGE, (Table S1) is involved in the activation of latent TGF-b3
[99] as well as TGF-b1 [100]. TGF-bs are secreted as latent
molecules and require activation prior to binding their signaling
receptor and the generation of active cytokine is one of the major
regulators of the TGF-b signaling pathway. The absence of b6
integrin recapitulates the phenotype of TGF-b1-null mice
indicating that this integrin is crucial for regulating TGF-b activity
[100]. We have previously shown that the stem cell enriched
proximal region of prostatic ducts has high levels of active TGF-b
and TGF-b signaling promotes quiescence of stem cells in this
region [44]. This signaling pathway is therefore likely to be an
important regulator of the prostatic stem cell niche.

Supporting Information
Table S1 Transcripts significantly expressed in the prostate
subset. Lists of transcripts that were significantly highly expressed
in the UGE compare to the UGM. The relative expression values
(LR) compared to the average expression values of UGM samples
are presented.
Found at: doi:10.1371/journal.pone.0013024.s001 (4.81 MB
XLS)

Conclusions

Table S2 Transcripts significantly expressed in the skin subset.

These data provide, for the first time, a comprehensive
description of the transcripts that are differentially expressed in
the embryonic UGE compared to the UGM and reflect the
molecular interactions that are likely to occur in the embryonic
prostate stem cell niche. To our knowledge this is the first
characterization of the potential signaling pathways and receptor/
ligand interactions in epithelial and mesenchymal compartments
isolated from a mammalian stem cell niche. As depicted in our
model shown in Figure 3, the differential gene expression of
specific signaling molecules in the UGE and the UGM may
potentially result in expression of protein ligand-recptor pairs that
mediate signal transductions in the embryonic prostate stem cell
niche. For example, self-renewal of stem cells in the embryonic
PLoS ONE | www.plosone.org

Lists of transcripts that were significantly highly expressed in the
epidermis compare to the dermis. The relative expression values
(LR) compared to the average expression values of dermis samples
are presented.
Found at: doi:10.1371/journal.pone.0013024.s002 (1.26 MB
XLS)
Table S3 Transcripts significantly expressed in the prostate and
the skin niches. Lists of transcripts that were significantly highly
expressed in each of the gene sets (Prostate-only UGE, Prostateonly UGM, Prostate+Skin UGE,Epidermis, Prost+Skin UGM,dermis, Skin-only epidermis, Skin-only dermis). Relative expression values (LR) are presented.
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Found at: doi:10.1371/journal.pone.0013024.s003 (3.51 MB
XLS)
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